Research Achievements
Hideaki Bujo| 2012 | 2011 | 2010 | 2009 | 2008 |
| Papers| International Conferences |
Papers
Tashiro‚ J.‚ Miyazaki‚ O.‚ Nakamura‚ Y.‚ Miyazaki‚ A.‚ Fukamachi‚ I.‚ Bujo‚ H. and Saito‚ Y. Plasma Pre¦Â1-HDL level is elevated in unstable angina pectoris.
Atherosclerosis 2009; 204 595-600
Matsuo M‚ Ebinuma H‚ Fukamachi I‚ Jiang M‚ Bujo H‚ Saito Y. Development of an Immunoassay for the Quantification of Soluble LR11‚ a Circulating Marker of Atherosclerosis.
Clin Chem. 2009; 55 (10): 1801-1808
Neff Y‚ Bujo H‚ Miyashita Y‚ Uchida D‚ Ban T‚ Tashiro T‚ Yamazaki K‚ Ishikawa K‚ Tokuyama T‚ Jiang M‚ Kawamura T‚ Saito‚ Y. The potential role of patient awareness regarding one¡Çs own medical data in the management of lifestyle-related.
ÀéÍÕ°å³Ø 2009; 85 125-134
International Conferences
Bujo H‚ Jiang M‚ Ohwaki K‚ Saito Y. Circulating sLR11‚ essential for the angiotensin II-induced intimal smooth muscle cell migration‚ is a biomarker of carotid atherosclerosis.
American Diabetes Association 69th Scientific Sessions 2009-6-6 New Orieans/U.S.A.
Bujo H‚ Jiang M‚ Ohwaki K‚ Schneider W J‚ Saito Y. LR11‚ a novel circulating marker of carotid atherosclerosis‚ is essential for angiotensin II -induced intimal smooth muscle cell migration
15th International Symposium on Atherosclerosis 2009-6-14 Boston/U.S.A.
Bujo H. Translational research started from two pathological cells - intimal smooth muscle cell and abdominal adipocyte
University of Cambridge Addenbrooke¡Çs Hospital IMS Seminar 2009-5-27 Cambridge/U.K.
Bujo H. Oxidized LDL and atherosclerosis –Expected role of probucol
PICASSO investigator meeting 2009-3-7 Seoul/Korea
